Follicular lymphoma is a very diverse disease, and decisions to treat in the frontline are made based on histology, disease burden and patient symptoms. The general approach should be a ...

—Most follicular lymphoma cases exhibit classic clinicopathologic and molecular features, but a range of less common histopathologic variants have been documented, confounding diagnosis and ...

FOR years, Taylor Deanne Roy dismissed her shortness of breath and itchy skin as signs she was simply “getting older”. So ...

What’s the next step for this patient with a 4-year history of low-grade follicular lymphoma and ... He was initially diagnosed 4 years ago, when he presented with bulky cervical and inguinal ...

Part B of the study reported on an additional 142 patients with relapsed or refractory indolent lymphoma (73% FL grade ... therapy within 24 months of diagnosis is associated with a particularly ...

The final diagnosis was diffuse large B-cell lymphoma (DLBCL) of follicular center origin involving the omentum, bilateral adnexal masses, and left ovary, with gastric implants. A repeat ...

Monjuvi, Revlimid and Rituxan improved progression-free survival among adults with relapsed or refractory follicular lymphoma, topline research showed.